文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

中年立陶宛人群中具有动脉粥样硬化性血脂异常患者的心血管风险特征。

Cardiovascular risk profile of patients with atherogenic dyslipidemia in middle age Lithuanian population.

机构信息

Faculty of Medicine, Clinic of Cardiac and Vascular Diseases, Vilnius University, Vilnius, Lithuania.

Faculty of Medicine, Vilnius University, Vilnius, Lithuania.

出版信息

Lipids Health Dis. 2018 Sep 5;17(1):208. doi: 10.1186/s12944-018-0851-0.


DOI:10.1186/s12944-018-0851-0
PMID:30185180
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6123979/
Abstract

BACKGROUND: Atherogenic dyslipidemia (AD) is a blood serum lipid profile abnormality characterized by elevation of triglycerides and reduced levels of high density lipoprotein cholesterol (HDL-C). It is associated with residual cardiovascular risk. This study evaluated and compared the risk profiles of patients with hypertriglyceridemia, low-HDL-C levels or AD, in order to understand, which lipid profile is associated with greater risk. METHODS: During the period of 2009-2016 a population of 92,373 Lithuanian adults (men 40-54 years old and women 50-64 years old) without overt cardiovascular disease were analyzed. Data of 25,746 patients (68.6% women and 31.4% men) with hypertriglyceridemia and/or low HDL-C low levels were collected and used for further statistical analysis. RESULTS: Participants with AD tend to have more unfavorable risk profile than participants with hypertriglyceridemia or low-HDL-C. AD tends to cluster with other atherogenic risk factors, such as arterial hypertension [odds ratio (OR) 1.96, 95% confidence intervals (CI) 1.87-2.01], smoking [OR 1.20, 95% CI 1.14-1.27], diabetes mellitus [OR 2.74, 95% CI 2.58-2.90], obesity [OR 2.92, 95% CI 2.78-3.10], metabolic syndrome [OR 22.27, 95% CI 20.69-23.97], unbalanced diet [OR 1,59, 95% CI 1.51-1.68], low physical activity [OR 1.80, 95% CI 1.71-1,89], CHD history in first degree relatives [OR 1.18, 95% CI 1.12-1.25] and total number of risk factors [OR 1.47, 95% CI 1.38-1.57]. CONCLUSION: AD is associated with more unfavorable cardiovascular risk profile than hypertriglyceridemia or low-HDL cholesterol levels. Once identified AD should require additional medical attention since it is an important factor of residual cardiovascular risk.

摘要

背景:动脉粥样硬化性血脂异常(AD)是一种血清脂质谱异常,其特征为甘油三酯升高和高密度脂蛋白胆固醇(HDL-C)水平降低。它与残余心血管风险相关。本研究旨在评估和比较高甘油三酯血症、低 HDL-C 血症或 AD 患者的风险特征,以了解哪种血脂谱与更大的风险相关。

方法:在 2009-2016 年期间,对 92373 名没有明显心血管疾病的立陶宛成年人(40-54 岁男性和 50-64 岁女性)进行了分析。收集了 25746 名(68.6%女性和 31.4%男性)高甘油三酯血症和/或低 HDL-C 血症患者的数据,并进行了进一步的统计分析。

结果:与高甘油三酯血症或低 HDL-C 血症患者相比,AD 患者的风险状况更差。AD 倾向于与其他动脉粥样硬化性危险因素聚集,如高血压[比值比(OR)1.96,95%置信区间(CI)1.87-2.01]、吸烟[OR 1.20,95%CI 1.14-1.27]、糖尿病[OR 2.74,95%CI 2.58-2.90]、肥胖[OR 2.92,95%CI 2.78-3.10]、代谢综合征[OR 22.27,95%CI 20.69-23.97]、饮食不均衡[OR 1.59,95%CI 1.51-1.68]、体力活动不足[OR 1.80,95%CI 1.71-1.89]、一级亲属中冠心病史[OR 1.18,95%CI 1.12-1.25]和危险因素总数[OR 1.47,95%CI 1.38-1.57]。

结论:与高甘油三酯血症或低 HDL-C 血症相比,AD 与更不利的心血管风险状况相关。一旦确定 AD,就需要额外的医疗关注,因为它是残余心血管风险的一个重要因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d783/6123979/5989d547dfea/12944_2018_851_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d783/6123979/ffcd113eb485/12944_2018_851_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d783/6123979/5989d547dfea/12944_2018_851_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d783/6123979/ffcd113eb485/12944_2018_851_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d783/6123979/5989d547dfea/12944_2018_851_Fig2_HTML.jpg

相似文献

[1]
Cardiovascular risk profile of patients with atherogenic dyslipidemia in middle age Lithuanian population.

Lipids Health Dis. 2018-9-5

[2]
Related cardiometabolic factors and prevalence of low HDL-cholesterol levels and atherogenic dyslipidemia. SIMETAP-AD study.

Clin Investig Arterioscler. 2021

[3]
Severe dyslipidemia and concomitant risk factors in the middle-aged Lithuanian adults: a cross-sectional cohort study.

Lipids Health Dis. 2018-4-19

[4]
Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.

Am J Cardiovasc Drugs. 2005

[5]
Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.

Clin Ther. 2007-8

[6]
Elevated triglycerides and low high-density lipoprotein cholesterol level as marker of very high risk in type 2 diabetes.

Curr Opin Endocrinol Diabetes Obes. 2018-4

[7]
Usefulness of atherogenic dyslipidemia for predicting cardiovascular risk in patients with angiographically defined coronary artery disease.

Am J Cardiol. 2007-11-15

[8]
Prevalence of atherogenic dyslipidemia: association with risk factors and cardiovascular risk in Spanish working population. "ICARIA" study.

Atherosclerosis. 2014-8

[9]
Six-year time-trend analysis of dyslipidemia among adults in Newfoundland and Labrador: findings from the laboratory information system between 2009 and 2014.

Lipids Health Dis. 2018-5-2

[10]
Prevalence of atherogenic dyslipidemia in primary care patients at moderate-very high risk of cardiovascular disease. Cardiovascular risk perception.

Clin Investig Arterioscler. 2014

引用本文的文献

[1]
Correlation of Atherosclerotic Dyslipidemia with Long-Term Stroke Recurrence in Patients Undergoing Intravenous Thrombolysis for Acute Ischemic Stroke.

Int J Gen Med. 2023-5-2

[2]
Deteriorative Effect of a Combination of Hypertriglyceridemia and Low High-Density Lipoprotein Cholesterolemia on Target Lesion Revascularization after Everolimus-Eluting Stent Implantation.

J Atheroscler Thromb. 2023-12-1

[3]
A Descriptive Study of Atherogenic Indices in Patients Admitted to a Tertiary Care Hospital.

Cureus. 2022-12-5

[4]
Are young Iranian women with metabolically healthy obesity at increased risk of CVD incidence?

J Vasc Bras. 2020-9-14

[5]
Atherogenic Index of Plasma (AIP) a Tool to Assess Changes in Cardiovascular Disease Risk Post Laparoscopic Sleeve Gastrectomy.

J Diabetes Res. 2020-8-1

[6]
Lower than average HDL cholesterol efflux capacity in Lithuanian population.

Lipids Health Dis. 2019-10-26

[7]
Is the coronary artery calcium score the first-line tool for investigating patients with severe hypercholesterolemia?

Lipids Health Dis. 2019-7-6

本文引用的文献

[1]
Prevalence and treatment of atherogenic dyslipidemia in the primary prevention of cardiovascular disease in Europe: EURIKA, a cross-sectional observational study.

BMC Cardiovasc Disord. 2017-6-17

[2]
Association of triglyceride-to-high density lipoprotein cholesterol ratio to cardiorespiratory fitness in men.

J Clin Lipidol. 2016

[3]
Atherogenic dyslipidemia and risk of silent coronary artery disease in asymptomatic patients with type 2 diabetes: a cross-sectional study.

Cardiovasc Diabetol. 2016-7-22

[4]
Low HDL cholesterol as a cardiovascular risk factor in rural, urban, and rural-urban migrants: PERU MIGRANT cohort study.

Atherosclerosis. 2016-3

[5]
Effects of add-on lipid-modifying therapy on top of background statin treatment on major cardiovascular events: A meta-analysis of randomized controlled trials.

Int J Cardiol. 2015-7-15

[6]
Aging and dyslipidemia: a review of potential mechanisms.

Ageing Res Rev. 2014-12-8

[7]
Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients.

BMJ. 2014-7-18

[8]
Prevalence of atherogenic dyslipidemia: association with risk factors and cardiovascular risk in Spanish working population. "ICARIA" study.

Atherosclerosis. 2014-8

[9]
Prevalence of atherogenic dyslipidemia in primary care patients at moderate-very high risk of cardiovascular disease. Cardiovascular risk perception.

Clin Investig Arterioscler. 2014

[10]
Atherogenic dyslipidemia.

Indian J Endocrinol Metab. 2013-11

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索